Symptoms of Breast Cancer Metastasis – What Should You Look For?
In this article
Breast cancer is the most common cancer among women worldwide. Although almost one in every 8 women encounters this disease at some point in life, increasing awareness and the wider use of screening methods such as mammography mean that nearly %90 of diagnoses are made at an early stage . At an early stage, the disease has not yet metastasized ; however, of cancer-related deaths, approximately %90 are due to metastasis . Knowing the signs of metastasis and keeping up with regular checkups are therefore critically important.
Metastasis is when tumor cells leave their original tissue, move to other organs through the blood, lymph or direct extension to neighboring tissues, and multiply there.
What are the symptoms of breast cancer metastasis?
In breast cancer, a single symptom specific to metastasis is difficult to identify. Signs and symptoms depend on the organ involved . Typical symptoms according to the most commonly involved organs are summarized below:
- Lung metastasis: shortness of breath (dyspnea), persistent cough, chest pain or abnormal lung findings on examination.
- Liver metastasis: Jaundice, nausea and vomiting, loss of appetite, right upper quadrant abdominal pain; elevated liver function tests.
- Bone metastasis: Particularly worsening at night, pain; elevated alkaline phosphatase (ALP) in laboratory testing.
Even for patients without metastatic disease, regular follow-up visits are very valuable; clinical examination and appropriately timed imaging help detect possible metastases early.
Where does breast cancer most commonly metastasize?
- Most often, it spreads to lymph nodes ; in addition, lungs, bones, liver and brain are organs prone to metastasis.
- In patients with metastatic disease, clinical and examination findings similar to early-stage breast cancer may occur; absence of symptoms alone is therefore not reassuring.
- In the axilla (armpit), not being able to feel lymph nodes does not mean there is no involvement ; therefore, at diagnosis, appropriate oncological imaging is essential.
📋 Practical Diagnostic Approach (Summary)
- Clinical assessment: Ask about organ-specific symptoms (shortness of breath, persistent bone pain, jaundice, neurological symptoms).
- Laboratory testing: Liver function tests; if bone involvement is suspected, alkaline phosphatase (ALP).
- Choice of imaging: For comprehensive staging, PET-CT; for the liver and brain, because of its sensitivity, MRI is preferred.
- Pathology/biopsy: Tissue confirmation of new lesions where possible; receptor status (ER/PR/HER2) may change.
⚠️ Emergency warning signs: Acute shortness of breath, a new severe headache/neurological deficit, suspected pathological fracture, rapidly progressive jaundice — without delay should be evaluated.
Key features of stage 4 breast cancer
When cancer spreads to distant organs through metastasis , it is called stage 4 . Survival varies with biology and treatment; clinical studies report median overall survival of ~24 months approximately. However, with favorable biology and treatment options, some patients live with their disease controlled for years .
📌 Indicators associated with a better prognosis
- Hormone positivity (ER/PR+): Sensitivity to endocrine treatments may allow longer periods of disease control.
- A small number of metastatic sites (oligometastatic disease): Additional approaches such as local ablation/surgery may be considered.
- Bone-only involvement or lymph node-dominant spread: Generally a better course than visceral (liver, lung) and brain involvement.
Treatment planning involves multiple factors: Age, overall condition (ECOG), tumor subtype (ER/PR/HER2), extent of metastasis and previous treatments are assessed together. In suitable patients, targeted medicines and immunotherapies may significantly prolong survival.
Tumor markers (CA 15-3, CA 27.29) and liquid biopsy
CA 15-3 and CA 27.29, serum biomarkers are not diagnostic. Because of high misleading potential (false positives/negatives) , they are not used to diagnose breast cancer.
Practical use: In metastatic disease, monitoring treatment response and in early-stage cases that have completed curative treatment, tracking trends during routine follow-up may be considered with clinical assessment and imaging together .
Liquid (blood-based) biopsy studies aim to use circulating tumor DNA (ctDNA) to predict recurrence earlier. Research is intensive , but for recurrence screening , a generally accepted/standard approval does not yet exist. Clinical decisions are still based on symptoms + examination + appropriate imaging .
Imaging notes and laboratory clues
- Systemic staging: PET-CT is preferred for comprehensive screening. However, liver and brain sensitivity may remain limited; for these organs, MRI is generally superior.
- Suspected bone metastasis: Clinically, pain is the most common finding. Laboratory testing may show elevated ALP as an accompanying finding. For targeted assessment, MRI and, when necessary, bone scintigraphy may be considered.
- Suspected liver metastasis: ALT/AST, GGT, ALP, bilirubin may be elevated; intrahepatic/extrahepatic bile duct obstruction may cause jaundice . In imaging, Liver MRI (with dynamic contrast) is preferred.
- Neurological symptoms: In the presence of headache, visual/speech disturbance or a focal deficit, Brain MRI is requested.
Summary: The “symptom → targeted investigation” approach is essential. In an asymptomatic patient, aggressive imaging based solely on marker fluctuations can lead to unnecessary procedures; decisions should be based on clinical assessment+laboratory tests+imaging and individualized to the patient.
When should you see a doctor?
- New or rapidly worsening shortness of breath, persistent cough, chest pain
- Worsening at night, bone pain, bone tenderness without trauma/suspected fracture
- Jaundice, dark urine, pale stools, generalized fatigue
- New-onset headache, visual/speech disturbance or neurological deficit
- In existing symptoms, a marked change or weight loss/loss of appetite
Related links
- When is surgery preferred for recurrent breast cancer?
- Guide to bone metastasis
- What is PET-CT?
- Liquid biopsy studies
Final word: Metastasis symptoms vary by organ. When you notice a symptom, talk to your doctor and plan personalized imaging and appropriate tests .
Sources
2. Yamamoto N, Watanabe T, Katsumata N, et al. Construction and validation of practical prognostic index for patients with metastatic breast cancer. J Clin Oncol. 1998
3. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996
4. Robertson JF, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW. Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy. Breast Cancer Res Treat. 1992
5. Stuart-Harris R, Shadbolt B, Palmqvist C, Chaudri Ross HA. The prognostic significance of single hormone receptor positive metastatic breast cancer: an analysis of three randomized phase III trials of aromatase inhibitors. Breast. 2009
6. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.